-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 NpYvsuXMX8Bm6BKIBI9ZVS8A59clqAbnqgTzNfQDs5js12ii64myKG0UYS8nawrH
 77AayY7wRHPEsoVPSXHOew==

<SEC-DOCUMENT>0000012208-08-000043.txt : 20081106
<SEC-HEADER>0000012208-08-000043.hdr.sgml : 20081106
<ACCEPTANCE-DATETIME>20081106164545
ACCESSION NUMBER:		0000012208-08-000043
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20080930
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20081106
DATE AS OF CHANGE:		20081106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO RAD LABORATORIES INC
		CENTRAL INDEX KEY:			0000012208
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				941381833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07928
		FILM NUMBER:		081167745

	BUSINESS ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DR
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547
		BUSINESS PHONE:		5107247000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8kcover09302008.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>UNITED STATES</TITLE>
<META NAME="author" CONTENT="Tom Brida">
<META NAME="date" CONTENT="04/21/2008">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:643.2px"><P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>UNITED STATES</B></P>
<P style="margin:0px" align=center><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="margin:0px" align=center><B>Washington, D.C. 20549</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="line-height:21.333px; margin:0px; font-size:18.667px" align=center><B>FORM 8-K</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="margin:0px" align=center><B>CURRENT REPORT</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>Date of Report: November 6, 2008</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Date of earliest event reported)</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="line-height:12px; margin:0px"><BR></P>
<P style="line-height:10.667px; margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:18.667px" align=center><B>BIO-RAD LABORATORIES, INC.</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Exact name of registrant as specified in its charter)</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="line-height:12px; margin:0px"><BR></P>
<P style="margin:0px" align=center><B>Commission File Number: 1-7928</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=360></TD><TD width=7.133></TD><TD width=352.8></TD></TR>
<TR><TD width=360><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD width=352.8><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=360><P style="margin:0px" align=center><B>Delaware</B></P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=top width=352.8><P style="margin:0px" align=center><B>94-1381833</B></P>
</TD></TR>
<TR><TD valign=top width=360><P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(State or other jurisdiction of</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>incorporation or organization)</B></P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=top width=352.8><P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(I.R.S. Employer</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>Identification No.)</B></P>
</TD></TR>
</TABLE>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="line-height:10.667px; margin:0px; font-size:10.667px">&nbsp;</P>
<P style="margin:0px" align=center><B>1000 Alfred Nobel Dr.</B></P>
<P style="margin:0px" align=center><B>Hercules, California 94547</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Address of principal executive offices, including zip code)</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<P style="margin:0px" align=center><B>(510) 724-7000</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Registrant&#146;s telephone number, including area code)</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="line-height:10.667px; margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="line-height:10.667px; margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=562.733></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=562.733><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=565.6></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=565.6><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=616.267></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=616.267><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=615></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=615><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><B>&nbsp;</B></P>
<P style="margin:0px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=83.333></TD><TD width=285.933></TD></TR>
<TR><TD valign=top width=83.333><P style="margin:0px" align=justify><B>ITEM 2.02</B></P>
</TD><TD valign=top width=285.933><P style="margin:0px"><B>Results of Operations and Financial Condition</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px">On November 6, 2008, Bio-Rad Laboratories, Inc. announced its results of operations and financial condition as of and for the quarter ended September 30, 2008. &nbsp;A copy of the press release is furnished as Exhibit 99.1 to this report.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed to be &#147;filed&#148; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. </P>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=83.333></TD><TD width=492.667></TD></TR>
<TR><TD valign=top width=83.333><P style="margin:0px"><B>ITEM 9.01</B></P>
</TD><TD valign=top width=492.667><P style="margin:0px"><B>Financial Statements and Exhibits</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=60></TD><TD width=24></TD><TD width=497.533></TD></TR>
<TR><TD width=60><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=24><P style="margin:0px">&nbsp;</P>
</TD><TD width=497.533><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=60><P style="margin:0px"><B>Exhibit</B></P>
<P style="margin:0px"><B>Number&nbsp;</B></P>
</TD><TD valign=bottom width=24><P style="margin:0px">&nbsp;</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=497.533><P style="margin:0px"><BR></P>
<P style="margin:0px"><B>Description</B></P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin-top:2.2px; margin-bottom:0px" align=right>99.1&nbsp;</P>
</TD><TD valign=bottom width=24><P style="margin-top:2.2px; margin-bottom:0px">&nbsp;</P>
</TD><TD valign=bottom width=497.533><P style="margin-top:2.2px; margin-bottom:0px">Press release of Bio-Rad Laboratories, Inc. dated November 6, 2008</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="margin:0px; page-break-before:always" align=center><B>SIGNATURES</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin:0px">&nbsp;&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=50.867></TD><TD width=136.333></TD><TD width=29.467></TD><TD width=29.467></TD><TD width=4></TD><TD width=253.867></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=257.867 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=257.867 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=287.333 colspan=3><P style="margin:0px">BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=257.867 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="margin:0px">Date:</P>
</TD><TD style="border-bottom:1px solid #000000" width=136.333><P style="margin:0px">November 6, 2008</P>
</TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="margin:0px">By:</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=257.867 colspan=2><P style="margin:0px">/s/ Christine A. Tsingos</P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=253.867><P style="margin:0px">Christine A. Tsingos </P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=253.867><P style="margin:0px">Vice President, Chief Financial Officer</P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="margin:0px">&nbsp;</P>
</TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=4><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=253.867><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<A NAME="id_11"></A><A NAME="id_12"></A><P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>EXHIBIT INDEX</B></P>
<P style="margin:0px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=34.2></TD><TD width=28.267></TD><TD width=513.533></TD></TR>
<TR><TD width=34.2><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=28.267><P style="margin:0px">&nbsp;</P>
</TD><TD width=513.533><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=34.2><P style="line-height:12px; margin:0px; font-size:9.333px"><B>Exhibit</B></P>
<P style="line-height:12px; margin:0px; font-size:9.333px"><B>Number</B></P>
</TD><TD valign=bottom width=28.267><P style="margin:0px; font-size:9.333px">&nbsp;</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=513.533><P style="line-height:12px; margin:0px; font-size:9.333px"><B>Description</B></P>
</TD></TR>
<TR><TD valign=top width=34.2><P style="margin:0px">99.1</P>
</TD><TD valign=bottom width=28.267><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=513.533><P style="margin:0px">Press release of Bio-Rad Laboratories, Inc. dated November 6, 2008</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>exh991093008.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>PART 1 &#8211; FINANCIAL INFORMATION</TITLE>
<META NAME="author" CONTENT="Stephanie Trudrung">
<META NAME="date" CONTENT="11/06/2008">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:604.8px"><P style="line-height:18.667px; margin:0px; font-size:16px" align=right><U>Exhibit 99.1</U></P>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=631.2></TD></TR>
<TR><TD valign=top width=631.2><P style="line-height:14.667px; margin:0px; padding-right:43.2px; font-family:Arial; font-size:12px"><FONT FACE="Arial"><B><I>FOR IMMEDIATE RELEASE</I></B></FONT></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="line-height:20px; margin:0px; padding-right:-24px; font-family:HelveticaNeueLT Std; font-size:17.333px" align=center><FONT FACE="HelveticaNeueLT Std"><B>BIO-RAD REPORTS THIRD-QUARTER 2008 SALES INCREASE OF 30%</B></FONT></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px"><B>HERCULES, CA &#150; November 6, 2008 &#150;</B> Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced financial results today for the third quarter ended September 30, 2008. &nbsp;</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">Third-quarter revenues were $441.8 million in 2008, up 30.1% compared to $339.7 million reported for the same period in 2007. This increase was due to organic growth across product areas in both the Life Science and Clinical Diagnostics segments as well as the addition of the products of DiaMed Holding AG acquired in the fourth quarter of 2007, which resulted in additional revenue of $63.5 million included in the third-quarter results. Excluding the revenue from the DiaMed products, third-quarter revenues were up 11.4%, or 5.6% on a currency-neutral basis, compared to the same quarter last year. <FONT COLOR=#0000FF>&nbsp;</FONT></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">Net income for the third quarter in 2008 was $27.8 million, or $1.01 per share on a fully diluted basis, compared to $28.0 million, or $1.03 per share reported for the same period in 2007. Reflected in operating income is $7.7 million of amortization of intangibles and purchase accounting adjustments associated with the DiaMed acquisition. Third-quarter gross margin was 54.4% compared to 55.4% in the third quarter last year. Of the previously mentioned DiaMed adjustments, $5.7 million was recorded in cost of goods sold. &nbsp;</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">Year-to-date revenues grew by 31.5% compared to the first three quarters in 2007 to $1.316 billion. On a currency neutral basis, growth was 24.5%. Excluding the additional revenue resulting from the DiaMed acquisition, year-to-date revenue for 2008 grew by 12.5% to $1.127 billion or 5.6% on a currency-neutral basis.<FONT COLOR=#00FFFF> </FONT>Year-to-date earnings per share for 2008 were $3.63 per share, or $3.55 per share<FONT COLOR=#0000FF> </FONT>on a fully diluted basis, and $3.03 and $2.96, respectively, for the same period of 2007. </P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px; padding-right:43.2px; font-family:HelveticaNeueLT Std" align=center>(more)</P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><P style="padding-left:0px; padding-top:0px; padding-right:43.2px; padding-bottom:0px; width:0px; font-family:Times New Roman; font-size:13.333px; color:#000000; page-break-before:always"><BR>
<BR></P>
<BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=631.2></TD></TR>
<TR><TD valign=top width=631.2><P style="margin:0px"><BR></P>
<P style="line-height:14.667px; margin:0px; padding-right:43.2px; font-family:HelveticaNeueLT Std; font-size:12px"><B><I>Bio-Rad Reports Third-Quarter 2008 Sales Increase of 30%</I></B></P>
<P style="line-height:14.667px; margin:0px; font-family:HelveticaNeueLT Std; font-size:12px"><B><I>Page 2</I></B></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">&nbsp;</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">&#147;We are encouraged by financial results of the third quarter, which reflect strength in many of our product areas despite a continuing soft capital equipment market,&#148; said Norman Schwartz, Bio-Rad President and Chief Executive Officer. &#147;As we move into the end of the fiscal year we will carefully monitor our global business for signs of economic pressure.&#148; </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px"><B>Life Science </B></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">Life Science segment net sales for the quarter were $156.9 million, up 9.7% compared to the same period last year. On a currency-neutral basis, segment sales increased by 4.4%. Contributing to these results were strong sales of electrophoresis, chromatography, and gel imaging products as well as Bio-Plex<SUP>&#174;</SUP> suspension array system reagents. Customer acceptance of Bio-Rad&#146;s next generation PCR instruments, the 1000-series thermal cycling and CFX Real Time platforms, continued to gain momentum during the third quarter. Capital instrument sales for the segment were down slightly in the quarter as a result of reduced spending by both academic and bio-pharmaceutical customers. Sales results in this segment were also somewhat tempered by continued erosion of BSE (bovine spongiform encephalopathy) testing revenue.</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px"><B>Clinical Diagnostics</B></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">The Clinical Diagnostics segment reported net sales of $281.4 million for the quarter, up 45.6% compared to the third quarter last year, or 39.4% on a currency neutral basis. &nbsp;&nbsp;Excluding revenue from the DiaMed acquisition, net sales were up 12.7% or 6.5%, on a currency neutral basis. These gains were the result of strong sales across a number of product lines, in particular, quality control, autoimmune, diabetes, and blood virus testing products. In September, Bio-Rad launched the BioPlex<SUP>&#174;</SUP> 2200 Syphilis IgM kit in Europe. The new test detects IgM class antibodies to a bacterium that causes syphilis. &nbsp;</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">Management will discuss these results in a conference call at 2 PM Pacific Time (5 PM Eastern Time) November 6, 2008. Interested parties can access the call by dialing 866-383-7989 (in the U.S.), or 617-597-5328 (international), access number 50351132. The live webcast can be accessed at http://www.bio-rad.com. A replay of the call will be available at 888-286-8010 (in the U.S.), or 617-801-6888 (international), access number 66463159, for seven days following the call and the webcast can be accessed at http://www.bio-rad.com for 30 days.</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; padding-right:43.2px; font-family:HelveticaNeueLT Std" align=center>(more)</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><P style="padding-left:0px; padding-top:0px; padding-right:43.2px; padding-bottom:0px; width:0px; font-family:Times New Roman; font-size:13.333px; color:#000000; page-break-before:always"><BR>
<BR></P>
<BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=631.2></TD></TR>
<TR><TD valign=top width=631.2><P style="margin:0px"><BR></P>
<P style="line-height:14.667px; margin:0px; padding-right:43.2px; font-family:HelveticaNeueLT Std; font-size:12px"><B><I>Bio-Rad Reports Third-Quarter 2008 Sales Increase of 30%</I></B></P>
<P style="line-height:14.667px; margin:0px; font-family:HelveticaNeueLT Std; font-size:12px"><B><I>Page 3</I></B></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px"><B>About Bio-Rad</B></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The Company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The Company employs over 6,300 people globally and had revenues approaching $1.5 billion in 2007. For more information, visit www.bio-rad.com. </P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-family:HelveticaNeueLT Std"><I>This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, &#147;believe,&#148; &#147;expect,&#148; &#147;may,&#148; &#147;will,&#148; &#147;intend,&#148; &#147;estimate,&#148; &#147;continue,&#148; or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the &#147;Risk Factors&#148; in the Company&#146;s public reports filed with the Securities and Exchange Commission, including the Company&#146;s Annual Report on Form 10-K for the fiscal year ended 
December 31, 2007, as updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. &nbsp;Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements. </I></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px"><B>For more information contact:</B></P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">Christine Tsingos, Vice President and Chief Financial Officer, or</P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">Ron Hutton, Treasurer</P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">Bio-Rad Laboratories, Inc.</P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">510-724-7000</P>
<P style="line-height:21.333px; margin:0px; font-family:HelveticaNeueLT Std; font-size:14.667px">investor_relations@bio-rad.com<FONT FACE="Courier New"> </FONT></P>
<P style="margin:0px"><BR></P>
</TD></TR>
</TABLE>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=341.933></TD><TD width=65.6></TD><TD width=11.8></TD><TD width=65.6></TD><TD width=19.467></TD><TD width=77.933></TD><TD width=12.133></TD><TD width=77.933></TD></TR>
<TR><TD valign=top width=672.4 colspan=8><P style="margin:0px" align=center><FONT FACE="Times New Roman">BIO-RAD LABORATORIES, INC.</FONT></P>
</TD></TR>
<TR><TD valign=top width=672.4 colspan=8><P style="margin:0px" align=center>Condensed Consolidated Statements of Income</P>
</TD></TR>
<TR><TD valign=top width=672.4 colspan=8><P style="margin:0px" align=center>(In thousands, except per share data)</P>
</TD></TR>
<TR><TD valign=top width=672.4 colspan=8><P style="margin:0px" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=341.933><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=143 colspan=3><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=168 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=341.933><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=143 colspan=3><P style="margin:0px" align=center>Three Months Ended</P>
</TD><TD valign=top width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=168 colspan=3><P style="margin:0px" align=center>Nine Months Ended</P>
</TD></TR>
<TR><TD valign=top width=341.933><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=143 colspan=3><P style="margin:0px" align=center>September 30,</P>
</TD><TD valign=top width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=168 colspan=3><P style="margin:0px" align=center>September 30,</P>
</TD></TR>
<TR><TD width=341.933><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=65.6><P style="margin:0px" align=right>2008</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=65.6><P style="line-height:14.667px; margin:0px" align=right>2007</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="line-height:14.667px; margin:0px" align=right>2008</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="line-height:14.667px; margin:0px" align=right>2007</P>
</TD></TR>
<TR><TD width=341.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=341.933><P style="margin:0px">Net sales</P>
</TD><TD width=65.6><P style="margin:0px" align=right>$ &nbsp;441,842&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="margin:0px" align=right>$ 339,742&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>$ 1,316,400&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>$ 1,001,364&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Cost of goods sold</P>
</TD><TD style="border-bottom:1px solid #000000" width=65.6><P style="margin:0px" align=right>201,300&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=65.6><P style="margin:0px" align=right>151,385&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="margin:0px" align=right>600,554&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="margin:0px" align=right>443,635&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px">Gross profit</P>
</TD><TD width=65.6><P style="margin:0px" align=right>240,542&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="margin:0px" align=right>188,357&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>715,846&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>557,729&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Selling, general and administrative expense</P>
</TD><TD width=65.6><P style="margin:0px" align=right>150,518&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="margin:0px" align=right>117,687&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>436,807&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>344,988&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Product research and development expense</P>
</TD><TD style="border-bottom:1px solid #000000" width=65.6><P style="margin:0px" align=right>38,830&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=65.6><P style="margin:0px" align=right>33,145&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="margin:0px" align=right>118,398&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="margin:0px" align=right>100,680&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px">Income from operations</P>
</TD><TD width=65.6><P style="margin:0px" align=right>51,194&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="margin:0px" align=right>37,525&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>160,641&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>112,061&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Interest expense</P>
</TD><TD width=65.6><P style="margin:0px" align=right>8,180&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="margin:0px" align=right>7,847&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>24,128&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>23,583&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Foreign exchange (gains) losses</P>
</TD><TD width=65.6><P style="margin:0px" align=right>91&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="margin:0px" align=right>257&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>2,396&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>(413)</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Other (income) expense, net</P>
</TD><TD style="border-bottom:1px solid #000000" width=65.6><P style="margin:0px" align=right>(523)</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=65.6><P style="margin:0px" align=right>(5,687)</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="margin:0px" align=right>(4,667)</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="margin:0px" align=right>(19,368)</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px">Income before taxes and minority interests</P>
</TD><TD width=65.6><P style="margin:0px" align=right>43,446&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="margin:0px" align=right>35,108&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>138,784&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>108,259&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Provision for income taxes</P>
</TD><TD width=65.6><P style="margin:0px" align=right>(12,557)</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="margin:0px" align=right>(7,137)</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>(34,012)</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="margin:0px" align=right>(27,620)</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Minority interests in earnings of</P>
</TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:26.667px">consolidated subsidiaries</P>
</TD><TD style="border-bottom:1px solid #000000" width=65.6><P style="margin:0px" align=right>(3,056)</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=65.6><P style="margin:0px" align=right>--&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="margin:0px" align=right>(7,046)</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="margin:0px" align=right>--&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px">Net income</P>
</TD><TD style="border-bottom:2.667px double #000000" width=65.6><P style="margin:0px" align=right>$ &nbsp;&nbsp;27,833&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=65.6><P style="margin:0px" align=right>$ &nbsp;&nbsp;27,971&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="margin:0px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;97,726&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="margin:0px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;80,639&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=341.933><P style="margin:0px">Basic earnings per share:</P>
</TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Net income</P>
</TD><TD style="border-bottom:2.667px double #000000" width=65.6><P style="margin:0px" align=right>$ &nbsp;&nbsp;1.03&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=65.6><P style="margin:0px" align=right>$ &nbsp;&nbsp;1.05&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="margin:0px" align=right>$ &nbsp;&nbsp;3.63&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="margin:0px" align=right>$ &nbsp;&nbsp;3.03&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Weighted average common shares</P>
</TD><TD style="border-bottom:2.667px double #000000" width=65.6><P style="margin:0px" align=right>27,029&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=65.6><P style="margin:0px" align=right>26,715&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="margin:0px" align=right>26,953&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="margin:0px" align=right>26,651&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=341.933><P style="margin:0px">Diluted earnings per share:</P>
</TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD width=65.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Net income</P>
</TD><TD style="border-bottom:2.667px double #000000" width=65.6><P style="margin:0px" align=right>$ &nbsp;&nbsp;1.01&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=65.6><P style="margin:0px" align=right>$ &nbsp;&nbsp;1.03&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="margin:0px" align=right>$ &nbsp;&nbsp;3.55&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="margin:0px" align=right>$ &nbsp;&nbsp;2.96&nbsp;</P>
</TD></TR>
<TR><TD width=341.933><P style="margin:0px; text-indent:19.2px">Weighted average common shares</P>
</TD><TD style="border-bottom:2.667px double #000000" width=65.6><P style="margin:0px" align=right>27,605&nbsp;</P>
</TD><TD width=11.8><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=65.6><P style="margin:0px" align=right>27,270&nbsp;</P>
</TD><TD width=19.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="margin:0px" align=right>27,517&nbsp;</P>
</TD><TD width=12.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="margin:0px" align=right>27,197&nbsp;</P>
</TD></TR>
<TR><TD width=672.4 colspan=8><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=672.4 colspan=8><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=672.4 colspan=8><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=391.667></TD><TD width=16.667></TD><TD width=104.467></TD><TD width=22.333></TD><TD width=108.533></TD></TR>
<TR><TD valign=top width=643.667 colspan=5><P style="margin:0px; font-size:12px" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=643.667 colspan=5><P style="margin:0px; font-size:12px" align=center>Condensed Consolidated Balance Sheets</P>
</TD></TR>
<TR><TD valign=top width=643.667 colspan=5><P style="margin:0px; font-size:12px" align=center>(In thousands)</P>
</TD></TR>
<TR><TD valign=top width=643.667 colspan=5><P style="margin:0px; font-size:12px" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=235.333 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=235.333 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=104.467><P style="margin:0px; font-size:12px" align=right>September 30,&nbsp;</P>
</TD><TD valign=top width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=108.533><P style="margin:0px; font-size:12px" align=right>December 31,&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=104.467><P style="margin:0px; font-size:12px" align=right>2008&nbsp;</P>
</TD><TD valign=top width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=108.533><P style="margin:0px; font-size:12px" align=right>2007&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; font-size:12px">Current assets: </P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=104.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=108.533><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; padding-left:19.2px; font-size:12px">Cash and cash equivalents</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;193,627&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;161,764&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; padding-left:19.2px; font-size:12px">Short-term investments</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>40,685&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>61,977&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; padding-left:19.2px; font-size:12px">Accounts receivable, net </P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>348,253&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>358,076&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; padding-left:19.2px; font-size:12px">Inventories, net </P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>383,266&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>321,015&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; padding-left:19.2px; font-size:12px">Other current assets</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=104.467><P style="line-height:14.667px; margin:0px; font-size:12px" align=right>117,615&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=108.533><P style="margin:0px; font-size:12px" align=right>126,142&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; text-indent:28.8px; font-size:12px">Total current assets </P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>1,083,446&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>1,028,974&nbsp;</P>
</TD></TR>
<TR><TD width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; font-size:12px">Net property, plant and equipment </P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>293,128&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>271,561&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; font-size:12px">Goodwill</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>325,641&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>328,439&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; font-size:12px">Purchased intangibles, net</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>199,769&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>210,304&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; font-size:12px">Other assets</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=104.467><P style="margin:0px; font-size:12px" align=right>112,961&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=108.533><P style="margin:0px; font-size:12px" align=right>132,316&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; text-indent:28.8px; font-size:12px">Total assets</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=104.467><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;2,014,945&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=108.533><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;1,971,594&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=104.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=108.533><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; font-size:12px">Current liabilities:</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=104.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=108.533><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; padding-left:19.2px; font-size:12px">Notes payable and current maturities of long-term debt</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=104.467><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11,886&nbsp;</P>
</TD><TD valign=top width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=108.533><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15,627&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; padding-left:19.2px; font-size:12px">Accounts payable</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>100,626&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>96,470&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; padding-left:19.2px; font-size:12px">Accrued payroll and employee benefits</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>107,502&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>121,255&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; padding-left:19.2px; font-size:12px">Sales, income and other taxes payable</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>32,985&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>27,905&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; padding-left:19.2px; font-size:12px">Other current liabilities</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=104.467><P style="margin:0px; font-size:12px" align=right>132,815&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=108.533><P style="margin:0px; font-size:12px" align=right>152,911&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; text-indent:28.8px; font-size:12px">Total current liabilities</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>385,814&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>414,168&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; font-size:12px">Long-term debt, net of current maturities</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>446,378&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>441,805&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; font-size:12px">Other long-term liabilities</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>96,934&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>109,497&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; font-size:12px">Minority interests</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=104.467><P style="margin:0px; font-size:12px" align=right>35,584&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=108.533><P style="margin:0px; font-size:12px" align=right>34,434&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; font-size:12px">Stockholders&#146; equity</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=104.467><P style="margin:0px; font-size:12px" align=right>1,050,235&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=108.533><P style="margin:0px; font-size:12px" align=right>971,690&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="margin:0px; text-indent:38.4px; font-size:12px">Total liabilities, minority interests and stockholders&#146; equity</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=104.467><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;2,014,945&nbsp;</P>
</TD><TD width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=108.533><P style="margin:0px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;1,971,594&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=391.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=104.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=22.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=108.533><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin-top:0px; margin-bottom:6px"><BR></P>
<P style="margin-top:0px; margin-bottom:6px"><BR>
<BR></P>
<P style="margin-top:0px; margin-bottom:6px; page-break-before:always"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=426.333></TD><TD width=77.333></TD><TD width=16.667></TD><TD width=77.333></TD></TR>
<TR><TD valign=top width=597.667 colspan=4><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=597.667 colspan=4><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>Condensed Consolidated Statements of Cash Flows</P>
</TD></TR>
<TR><TD valign=top width=597.667 colspan=4><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>(In thousands)</P>
</TD></TR>
<TR><TD valign=top width=597.667 colspan=4><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>(Unaudited) &nbsp;</P>
</TD></TR>
<TR><TD valign=top width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=171.333 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=171.333 colspan=3><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>Nine Months Ended</P>
</TD></TR>
<TR><TD valign=top width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=171.333 colspan=3><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>September 30,</P>
</TD></TR>
<TR><TD valign=top width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=77.333><P style="line-height:13.333px; margin:0px; font-size:12px" align=right>2008&nbsp;</P>
</TD><TD valign=top width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=77.333><P style="line-height:13.333px; margin:0px; font-size:12px" align=right>2007&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Cash flows from operating activities:</P>
</TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Cash received from customers</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;1,318,003&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;1,007,292&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Cash paid to suppliers and employees</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(1,152,538)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(880,104)</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Interest paid</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(24,141)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(24,008)</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Income tax payments</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(31,053)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(32,720)</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Litigation settlement</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(3,344)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(3,147)</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Other operating activities</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>6,103&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>21,116&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Net cash provided by operating activities</P>
</TD><TD style="border-top:1px solid #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>113,030&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>88,429&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Cash flows from investing activities:</P>
</TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Payments for acquisitions and long-term investments</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(18,069)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(2,496)</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Other investing activities</P>
</TD><TD style="border-bottom:1px solid #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(63,799)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>142,554&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Net cash provided by (used in) investing activities</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(81,868)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>140,058&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Cash flows from financing activities:</P>
</TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; text-indent:19.2px; font-size:12px">Payments on long-term debt</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(9,349)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(488)</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; text-indent:19.2px; font-size:12px">Other financing activities</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>13,758&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>13,078&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; text-indent:19.2px; font-size:12px">Net cash provided by financing activities</P>
</TD><TD style="border-top:1px solid #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>4,409&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>12,590&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Effect of exchange rate changes on cash</P>
</TD><TD style="border-bottom:1px solid #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(3,708)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>8,108&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Net increase in cash and cash equivalents</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>31,863&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>249,185&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Cash and cash equivalents at beginning of the period</P>
</TD><TD style="border-bottom:1px solid #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>161,764&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>223,607&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Cash and cash equivalents at end of period</P>
</TD><TD style="border-bottom:2.667px double #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;193,627&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;472,792&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=503.667 colspan=2><P style="line-height:14.667px; margin:0px; font-size:12px">Reconciliation of net income to net cash provided by operating activities:</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin:0px; font-size:12px">Net income </P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;97,726&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;80,639&nbsp;</P>
</TD></TR>
<TR><TD width=503.667 colspan=2><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Adjustments to reconcile net income to net cash provided by operating activities:&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; text-indent:19.2px; font-size:12px">Depreciation and amortization</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>74,322&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>43,406&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; text-indent:19.2px; font-size:12px">Changes in working capital</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(67,670)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(43,570)</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Litigation settlement</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(3,344)</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>(3,147)</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; padding-left:19.2px; font-size:12px">Other</P>
</TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>11,996&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>11,101&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px">Net cash provided by operating activities</P>
</TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;113,030&nbsp;</P>
</TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=77.333><P style="line-height:14.667px; margin-top:0px; margin-bottom:1px; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;88,429&nbsp;</P>
</TD></TR>
<TR><TD width=426.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=16.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
